石四药集团今日盘中股价大跌5.30%，市场表现疲软。
消息面上，公司于前一交易日盘后发布盈利警告，预计2025年度溢利将较上年度的10.61亿元大幅下降45%至60%。公司解释，业绩下滑主要由于国内没有大规模流行病发生，叠加医保控费导致药品终端销量下降；同时，带量采购范围扩大以及国内外行业竞争加剧，带来了持续的价格压力；此外，盐酸溴己新注射液不再通过国家药品集采销售，也导致了营业额的下降。
这份盈警公告揭示了公司面临的多重经营压力，包括需求端疲软、政策影响以及激烈的市场竞争，这些因素共同打击了投资者信心，引发了股价的显著下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.